These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11118390)

  • 1. Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998.
    Murphy EL; Assmann SF; Collier AC; Flanigan TP; Kumar PN; Wallach FR; Krubel S
    Clin Infect Dis; 2001 Jan; 32(1):116-23. PubMed ID: 11118390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002.
    Brooks JT; Song R; Hanson DL; Wolfe M; Swerdlow DL;
    Clin Infect Dis; 2005 Aug; 41(4):549-53. PubMed ID: 16028167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stopping preventive treatments.
    Fornataro K; Jefferys R
    Body Posit; 1999 Jul; 12(7):9-10. PubMed ID: 11367080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of opportunistic infections in HIV/AIDS.
    Goldschmidt RH
    Am Fam Physician; 1997 Sep; 56(4):1039-40. PubMed ID: 9310055
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple opportunistic pathogen prophylaxis for patients with advanced HIV disease: an overview.
    Jacobson MA
    AIDS Clin Rev; 1995-1996; ():47-63. PubMed ID: 7488560
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylaxis of opportunistic infections in adults and children with HIV infection.
    AIDS Inst Newsl; 1995 Jun; ():1-12. PubMed ID: 11367408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHS guidelines map out prevention routes through terrain of infections. Public Health Service.
    AIDS Alert; 1995 Sep; 10(9):109-11. PubMed ID: 11362773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy.
    Powderly WG
    Clin Infect Dis; 2000 Aug; 31(2):597-601. PubMed ID: 10987727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.
    Clin Infect Dis; 1997 Oct; 25 Suppl 3():S313-35. PubMed ID: 9356832
    [No Abstract]   [Full Text] [Related]  

  • 10. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).
    Infect Dis Obstet Gynecol; 2000; 8(1):5-74. PubMed ID: 10741830
    [No Abstract]   [Full Text] [Related]  

  • 11. Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.
    Mussini C; Pezzotti P; Antinori A; Borghi V; Monforte Ad; Govoni A; De Luca A; Ammassari A; Mongiardo N; Cerri MC; Bedini A; Beltrami C; Ursitti MA; Bini T; Cossarizza A; Esposito R;
    Clin Infect Dis; 2003 Mar; 36(5):645-51. PubMed ID: 12594647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease.
    Currier JS; Williams P; Feinberg J; Becker S; Owens S; Fichtenbaum C; Benson C;
    Clin Infect Dis; 2001 Jun; 32(11):1615-22. PubMed ID: 11340534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foregoing prophylaxis: better safe than sorry?
    Gaylord G
    Posit Living; 1999 Nov; 8(10):44. PubMed ID: 11367330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of common HIV-associated opportunistic complications.
    Carmichael C
    Prim Care; 1997 Sep; 24(3):561-74. PubMed ID: 9271692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preaching what we practice: new guidelines for OI prophylaxis.
    Feinberg J
    AIDS Clin Care; 1999 Nov; 11(11):87-9, 94. PubMed ID: 11366709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virus.
    Cheever LW; Chaisson RE; Gallant JE
    West J Med; 1996; 165(1-2):67-73. PubMed ID: 8855697
    [No Abstract]   [Full Text] [Related]  

  • 17. Opportunistic infections: stemming the tide.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Apr; 3(4):42-7. PubMed ID: 11364202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of patients infected by the human immunodeficiency virus (HIV). Report of an expert group].
    Delfraissy JF;
    Rev Pneumol Clin; 2002 Dec; 58(6 Pt 1):312-40. PubMed ID: 12545131
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged fever due to Mycobacterium avium complex (MAC) disease in advanced HIV infection: a public health concern.
    Suwanagool S; Kolladarungkri T; Leelarasamee A; Chuenarom V; Jearanaisilavong J; Chaiprasert A
    J Med Assoc Thai; 1998 Nov; 81(11):893-905. PubMed ID: 9803090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on opportunistic infections.
    Proj Inf Perspect; 1997 Nov; (23):16-7. PubMed ID: 11365373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.